# Fomepizole Dosing During Continuous Renal Replacement Therapy (CRRT)

> **NCT04649138** · — · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 11 (actual)

## Conditions studied

- Toxic Alcohol Poisoning

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04649138
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2020-11-26
- **Final completion:** 2020-11-26
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649138, "Fomepizole Dosing During Continuous Renal Replacement Therapy (CRRT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04649138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*